Literature DB >> 18514122

Histologic classification of thymoma: the World Health Organization and beyond.

Saul Suster1, Cesar A Moran.   

Abstract

Thymoma classification has remained for many years a troubled and contentious field. In recent years, the World Health Organization (WHO) presented a proposal for the histopathologic classification of thymic epithelial neoplasms that has been adopted as the standard by many pathologists throughout the world. Yet, controversy still exists regarding its validity, accuracy, usefulness, and reproducibility in routine clinical practice. This article reviews the basic criteria of the current WHO classification of thymoma, along with its weaknesses and limitations, and presents alternate proposals for the histopathologic approach to the classification of thymic epithelial neoplasms.

Entities:  

Mesh:

Year:  2008        PMID: 18514122     DOI: 10.1016/j.hoc.2008.03.001

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  19 in total

Review 1.  The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes.

Authors:  Alexander Marx; John K C Chan; Jean-Michel Coindre; Frank Detterbeck; Nicolas Girard; Nancy L Harris; Elaine S Jaffe; Michael O Kurrer; Edith M Marom; Andre L Moreira; Kiyoshi Mukai; Attilio Orazi; Philipp Ströbel
Journal:  J Thorac Oncol       Date:  2015-10       Impact factor: 15.609

2.  A comparative study of the spatial distribution of mast cells and microvessels in the foetal, adult human thymus and thymoma.

Authors:  Marius Raica; Anca Maria Cimpean; Beatrice Nico; Diego Guidolin; Domenico Ribatti
Journal:  Int J Exp Pathol       Date:  2009-12-04       Impact factor: 1.925

3.  A phase I/II trial of belinostat in combination with cisplatin, doxorubicin, and cyclophosphamide in thymic epithelial tumors: a clinical and translational study.

Authors:  Anish Thomas; Arun Rajan; Eva Szabo; Yusuke Tomita; Corey A Carter; Barbara Scepura; Ariel Lopez-Chavez; Min-Jung Lee; Christophe E Redon; Ari Frosch; Cody J Peer; Yuanbin Chen; Richard Piekarz; Seth M Steinberg; Jane B Trepel; William D Figg; David S Schrump; Giuseppe Giaccone
Journal:  Clin Cancer Res       Date:  2014-09-04       Impact factor: 12.531

Review 4.  Thymoma and thymic carcinoma.

Authors:  Federico Venuta; Erino A Rendina; Marco Anile; Tiziano de Giacomo; Domenico Vitolo; Giorgio F Coloni
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-01-13

5.  Histogram analysis of apparent diffusion coefficient maps for assessing thymic epithelial tumours: correlation with world health organization classification and clinical staging.

Authors:  Ling-Yan Kong; Wei Zhang; Yue Zhou; Hai Xu; Hai-Bin Shi; Qing Feng; Xiao-Quan Xu; Tong-Fu Yu
Journal:  Br J Radiol       Date:  2018-01-10       Impact factor: 3.039

6.  Immune-mediated diseases and immunodeficiencies associated with thymic epithelial neoplasms.

Authors:  Muhammad Rizwan Khawaja; Robert P Nelson; Nicholas Miller; Sunil S Badve; Elizabeth Loehrer; Magdalena Czader; Susan M Perkins; Kenneth Kesler; Patrick J Loehrer
Journal:  J Clin Immunol       Date:  2012-01-08       Impact factor: 8.317

7.  Thymic epithelial tumor with heart metastasis in a horse.

Authors:  Farshid Shahriar; Janet Moore
Journal:  Vet Med Int       Date:  2010-08-08

8.  FDG PET-CT aids in the preoperative assessment of patients with newly diagnosed thymic epithelial malignancies.

Authors:  Marcelo F K Benveniste; Cesar A Moran; Osama Mawlawi; Patricia S Fox; Stephen G Swisher; Reginald F Munden; Edith M Marom
Journal:  J Thorac Oncol       Date:  2013-04       Impact factor: 15.609

Review 9.  Treatment of advanced thymoma and thymic carcinoma.

Authors:  Arun Rajan; Giuseppe Giaccone
Journal:  Curr Treat Options Oncol       Date:  2009-04-21

10.  Clinicopathological analysis of 241 thymic epithelial tumors-experience in the Shanghai Chest Hospital from 1997-2004.

Authors:  Lei Zhu; Jie Zhang; Alexander Marx; Christel Weiss; Wen-Tao Fang
Journal:  J Thorac Dis       Date:  2016-04       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.